Neurological evaluation of patients with Gaucher disease diagnosed as type 1

被引:52
作者
Capablo, J. L. [1 ]
de Cabezon, A. Saenz [2 ]
Fraile, J. [3 ]
Alfonso, P. [4 ]
Pocovi, M. [4 ]
Giraldo, P. [5 ]
机构
[1] Miguel Servet Univ Hosp, Dept Neurol, Zaragoza, Spain
[2] Miguel Servet Univ Hosp, Dept Neurophysiol, Zaragoza 50006, Spain
[3] Miguel Servet Univ Hosp, ORL Dept, Zaragoza 50006, Spain
[4] Univ Zaragoza, Dept Biochem Cellular & Mol Cell Biol, E-50009 Zaragoza, Spain
[5] Miguel Servet Univ Hosp, Dept Haematol, Zaragoza 50006, Spain
关键词
D O I
10.1136/jnnp.2006.111518
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Type 1 Gaucher disease (GD1) is characterised by lack of central nervous system involvement; however, there are several reports of associated neurological manifestations. The aim of this study was to systematically evaluate neurological manifestations in 31 patients with GD1 (12 males and 19 females; mean age 39.4 (range 5-77) years). Participants underwent a complete neurological examination and cognitive tests. Investigation of symptoms and medication intake, and motor and sensory electroneurograms were obtained. 30.7% of adult patients had neurological deficits, including psychomotor delay, parkinsonism, dementia, impaired saccadic ocular movements and peripheral nerve dysfunction. Three patients were redefined as type 3 GD. Electrodiagnosis was performed on 15 patients; 26.7% had reduced amplitude and/or abnormal waveforms in at least three nerves, 33.3% had a mild reduction in amplitude of two nerves and 40% had amplitude reduction in one nerve. Patients with three or more affected nerves had additional neurological symptoms. Our results demonstrate that neurological alterations occur in patients diagnosed with GD1, and subclinical peripheral neuropathy is a frequent finding.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 15 条
[1]   Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews [J].
Aharon-Peretz, J ;
Rosenbaum, H ;
Gershoni-Baruch, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1972-1977
[2]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[3]  
Böhm P, 2005, NEUROLOGIA, V20, P402
[4]  
Connock M., 2006, HEALTH TECHNOL ASSES, V10, pix, DOI DOI 10.3310/HTA10240
[5]  
Giraldo P, 2000, HAEMATOLOGICA, V85, P792
[6]   Increased incidence of Parkinson disease among relatives of patients with Gaucher disease [J].
Halperin, Assaf ;
Elstein, Deborah ;
Zimran, Ani .
BLOOD CELLS MOLECULES AND DISEASES, 2006, 36 (03) :426-428
[7]   NEUROLOGICAL INVOLVEMENT IN TYPE-1 (ADULT) GAUCHERS-DISEASE [J].
MCKERAN, RO ;
BRADBURY, P ;
TAYLOR, D ;
STERN, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (02) :172-175
[8]   Therapeutic goals in Gaucher disease [J].
Mistry, P .
REVUE DE MEDECINE INTERNE, 2006, 27 :S30-S33
[9]   Chronic polyneuropathies in Vest-Agder, Norway [J].
Mygland, Å ;
Monstad, P .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (02) :157-165
[10]   A neurological symptom survey of patients with type I Gaucher disease [J].
Pastores, GM ;
Barnett, NL ;
Bathan, P ;
Kolodny, EH .
JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) :641-645